Immunology News and Research

Latest Immunology News and Research

New treatment protects nonhuman primates against Lassa fever eight days after infection

A collaborative team of scientists, led by a group at The University of Texas Medical Branch at Galveston, have successfully protected nonhuman primates against one of the most deadly viruses in the world, Lassa fever, eight days after they became infected.

6 Sep 2017

Biodegradable nanoparticle injected after spinal cord injury limits damage

After a spinal cord injury, a significant amount of secondary nerve damage is caused by inflammation and internal scarring that inhibits the ability of the nervous system to repair itself.

5 Sep 2017

Older wombs have more trouble in adapting to pregnancy

Deciding to start a family later in life could be about more than just the age of your eggs. A new study in mice suggests the age of a mother's womb may also have a part to play.

5 Sep 2017

Zika virus may one day be effective treatment for deadly brain cancer

While Zika virus causes devastating damage to the brains of developing fetuses, it one day may be an effective treatment for glioblastoma, a deadly form of brain cancer.

5 Sep 2017

Unfolded protein response could be cause of metabolic disorders, say researchers

The cell's response to unfolded or misfolded proteins could be a cause, rather than a consequence, of metabolic disorders, report researchers at the Medical University of South Carolina in an article published online ahead of print on September 4, 2017 by Nature Structural & Molecular Biology.

4 Sep 2017

Breastfeeding may protect children from asthma exacerbations later in life

In a Pediatric Allergy and Immunology analysis of children with asthma, those who had been breastfed had a 45% lower risk of asthma exacerbations later in life compared with children who had not been breastfed.

1 Sep 2017

Beta blockers capable of reducing stress signaling may enhance effectiveness of immunotherapy

While the development of therapies designed to block "checkpoints" within the immune system has been one of the most exciting and noteworthy advances in cancer research in recent years, it's also been one of the most puzzling, leaving researchers to ask: Why don't these new therapies work for more patients, and why is their efficacy in controlling cancerous tumors often short-lived? A research team from Roswell Park Cancer Institute has shown that at least one answer - and an excellent opportunity for unleashing the full potential of these promising immunotherapies - may lie in the body's "fight or flight" reaction to stressors and in drugs already widely used to control and temporarily disable this stress response.

31 Aug 2017

Gout patient hospitalizations: what’s causing the increase?

We looked at all hospitalizations in patients with gout. The concern is that gout is often considered as a disease of just the joints, specifically of the big toe. Yet, there have been quite a lot of studies that have talked about the many other comorbidities that occur because of hyperuricemia and gout. The idea is that it's not just the crystal deposits in the joint, but other consequences that are happening because of this disease in the rest of the body.

31 Aug 2017

Immunotherapy that uses existing cancer drugs in a new way delivers promising results

Immunotherapy is an emerging field in the global fight against cancer, even though scientists and clinicians have been working for decades to find ways to help the body's immune system detect and attack cancerous cells.

29 Aug 2017

Extensive analysis reveals immune system dynamics after stem cell transplantation in leukemia patients

By combining new system-biological analyses and advanced data analysis, researchers at Karolinska Institutet have been able to monitor the maturation process of the immune system of leukemia patients who have undergone stem cell transplantation.

29 Aug 2017

GW study to explore the body's natural defenses against HIV

A research team at the George Washington University School of Medicine and Health Sciences will study the body's natural defenses against HIV and look for ways to eliminate the infectious HIV reservoirs in the white blood cells of people taking antiretroviral therapy.

28 Aug 2017

Offshore rush for herpes vaccine roils debate over U.S. safety rules

Defying U.S. safety protections for human trials, an American university and a group of wealthy libertarians, including a prominent Donald Trump supporter, are backing the offshore testing of an experimental herpes vaccine.

28 Aug 2017

Simultaneous treatment with anti-PD1 and anti-OX40 cancer therapies may have detrimental effect

Concurrent administration of the T-cell stimulating anti-OX40 antibody and the immune checkpoint inhibitor anti-PD1 antibody attenuated the effect of anti-OX40 and resulted in poor treatment outcomes in mice.

28 Aug 2017

SLU-led project receives NIH funding for clinical trial on potential treatment for MDR-TB

Saint Louis University is leading a multi-national clinical trial of what could become a regimen for drug resistant tuberculosis (TB) that does not require injectable medications. The project is funded by a $6.4 million task order from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

26 Aug 2017

LSU Health New Orleans receives $10 million grant to support research on virus-induced cancers

The National Institute of General Medical Sciences has awarded LSU Health New Orleans a $10 million grant over five years to support new basic research studies advancing the development new diagnostic and therapeutic approaches for virus-induced cancers.

26 Aug 2017

Bioinformatics expert receives $12.8 million grant to continue to lead Diabetic Complications Consortium

Dr. Richard A. McIndoe, bioinformatics expert and associate director of the Center for Biotechnology and Genomic Medicine at the Medical College of Georgia at Augusta University, has received a $12.8 million grant to continue to lead a national research initiative focused on reducing the complications of diabetes.

26 Aug 2017

NIH grant for CWRU professors could enable new directions for cancer immunotherapies

Nicole Steinmetz, PhD, Associate Professor of Biomedical Engineering, Radiology, member of the Case Comprehensive Cancer Center and the Center for RNA Science and Therapeutics in the Division of General Medical Sciences at Case Western Reserve University School of Medicine and the holder of the George J. Picha Designated Professor in Biomaterials, has received a major grant from the National Institutes of Health to help understand how a virus-like particle from plants stimulates potent anti-tumor responses.

26 Aug 2017

Yale experts uncover genes associated with immune response to flu vaccination

Yale experts and their partners in a national research consortium have identified several genes and gene clusters associated with the immune response to flu vaccination.

26 Aug 2017

Pan-European initiative receives €3.7 million funding to train next generation of brain tumor researchers

A pan-European initiative led by the University of Plymouth designed to train the next generation of brain tumor researchers, has received funding of almost €3.7 million from the European Commission's Horizon 2020 - Research and Innovation Framework Program.

26 Aug 2017

Gut bacteria in Hadza diet different from ours study finds

Probiotics are one of the fastest growing areas for research as well as one of the valued members in the food industry. These are healthy bacteria or friendly bacteria that are added to yogurts, drinks, and baby food in order to colonize out gut when we are taking antibiotics or are down with an intestinal infection.

24 Aug 2017

Immunology News and Research

Latest Immunology News and Research

New treatment protects nonhuman primates against Lassa fever eight days after infection

Biodegradable nanoparticle injected after spinal cord injury limits damage

Older wombs have more trouble in adapting to pregnancy

Zika virus may one day be effective treatment for deadly brain cancer

Unfolded protein response could be cause of metabolic disorders, say researchers

Breastfeeding may protect children from asthma exacerbations later in life

Beta blockers capable of reducing stress signaling may enhance effectiveness of immunotherapy

Gout patient hospitalizations: what’s causing the increase?

Immunotherapy that uses existing cancer drugs in a new way delivers promising results

Extensive analysis reveals immune system dynamics after stem cell transplantation in leukemia patients

GW study to explore the body's natural defenses against HIV

Offshore rush for herpes vaccine roils debate over U.S. safety rules

Simultaneous treatment with anti-PD1 and anti-OX40 cancer therapies may have detrimental effect

SLU-led project receives NIH funding for clinical trial on potential treatment for MDR-TB

LSU Health New Orleans receives $10 million grant to support research on virus-induced cancers

Bioinformatics expert receives $12.8 million grant to continue to lead Diabetic Complications Consortium

NIH grant for CWRU professors could enable new directions for cancer immunotherapies

Yale experts uncover genes associated with immune response to flu vaccination

Pan-European initiative receives €3.7 million funding to train next generation of brain tumor researchers

Gut bacteria in Hadza diet different from ours study finds

eBook: Cell-based technologies in drug discovery and Immunotherapy eBook

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows